Bright Minds Biosciences Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Bright Minds Biosciences Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-102.8×Operating cash was negative last year, while some debt falls due within a year.
Lower than 83% of Healthcare companies in United States.
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Bright Minds Biosciences Inc. made a loss over the last year. Bright Minds Biosciences Inc. owes C$0.01 for every C$1 it owns. Bright Minds Biosciences Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Sep 2025.
P/E ratio
LossBright Minds Biosciences Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.37The share price is 2.37 times Bright Minds Biosciences Inc.'s book value per share, lower than 53% of Healthcare companies in United States.
Market cap
$520 MThe total market value of all of Bright Minds Biosciences Inc.'s shares at today's price (share price × number of shares), larger than 55% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
C$308 MWhat Bright Minds Biosciences Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Return on equity (ROE)
-13.6%Bright Minds Biosciences Inc. lost 13.6% of its shareholders' money over the last year, higher than 69% of Healthcare companies in United States.
Owes vs Owns
0.01×Bright Minds Biosciences Inc. owes C$0.01 for every C$1 it owns (low), lower than almost all Healthcare companies in United States.
Dividend yield
NoneBright Minds Biosciences Inc. does not currently pay a dividend.
Profit growth
LossBright Minds Biosciences Inc. made a loss in each of the last two years.
Cash vs debt
Net cashBright Minds Biosciences Inc. held C$83 M more cash than debt (net cash) at Sep 2025.
Questions
What is Bright Minds Biosciences Inc.'s return on equity?
Bright Minds Biosciences Inc. lost 13.6% of its shareholders' money over the last year, higher than 69% of Healthcare companies in United States.
How much does Bright Minds Biosciences Inc. owe compared with what it owns?
Bright Minds Biosciences Inc. owes C$0.01 for every C$1 it owns (low), lower than almost all Healthcare companies in United States.
Does Bright Minds Biosciences Inc. pay a dividend?
No. Bright Minds Biosciences Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.